4-thiazolidinone-based derivatives rosiglitazone and pioglitazone affect the expression of antioxidant enzymes in different human cell lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

4-thiazolidinone-based derivatives rosiglitazone and pioglitazone affect the expression of antioxidant enzymes in different human cell lines

Published:2021-07 Issue: Volume:139 Page:111684
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Szychowski Konrad A.,Skóra Bartosz,Kryshchyshyn-Dylevych Anna,Kaminskyy Danylo,Khyluk Dmytro,Lesyk Roman

Funder

Wyzsza Szkola Informatyki i Zarzadzania z siedziba w Rzeszowie

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference44 articles.

1. PPARγ and apoptosis in cancer;Elrod;PPAR Res.,2008

2. The role of PPARs in Cancer;Tachibana;PPAR Res,2008

3. PPAR gamma gene - a review;Janani;Diabetes Metab. Syndr. Clin. Res. Rev.,2015

4. Cross-talk between PPARγ and insulin signaling and modulation of insulin sensitivity;Leonardini;PPAR Res.,2009

5. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases;Monsalve;Mediat. Inflamm.,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Properties of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Potential Agonists 4-Thiazolidinone-Pyrazoline Hybrids Les-4368 and Les-4370 in Colorectal Adenocarcinoma Cells In Vitro;Applied Sciences;2024-08-30

2. Role of 4-Thiazolidinone–Pyrazoline/Indoline Hybrids Les-4369 and Les-3467 in BJ and A549 Cell Lines;Cells;2024-06-08

3. Based on the Network Pharmacology to Analyze the Effect of Chuanxiong in Improving Diabetic Nephropathy;Letters in Drug Design & Discovery;2024-03

4. Targeting PPARs for therapy of atherosclerosis: A review;International Journal of Biological Macromolecules;2023-07

5. ROSIGLITAZONE, A REPURPOSED DRUG AS ANTICANCER AGENT: A REVIEW;Towards Excellence;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3